Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)

This article has no abstract
Epistemonikos ID: e277496564ebdd1ff60753ecdb5f6704f2a3606c
First added on: Feb 19, 2025